Grapefruit USA, Inc.
General ticker "GPFT" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $823.4K (TTM average)
Grapefruit USA, Inc. does not follow the US Stock Market performance with the rate: -7.1%.
Estimated limits based on current volatility of 13.5%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 9 as of 2008
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.00$, 0.00$]
- 2024-12-30 to 2025-12-30 estimated range: [0.00$, 0.00$]
Financial Metrics affecting the GPFT estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.55 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -452.41 <= 18.93
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 6.98 > -0.66
Short-term GPFT quotes
Long-term GPFT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.59MM | $0.04MM | $0.00MM |
| Operating Expenses | $3.00MM | $2.23MM | $0.93MM |
| Operating Income | $-2.42MM | $-2.19MM | $-0.93MM |
| Non-Operating Income | $-3.09MM | $-1.58MM | $-0.92MM |
| Interest Expense | $1.68MM | $1.47MM | $1.11MM |
| Income(Loss) | $-5.51MM | $-3.78MM | $-1.85MM |
| Profit(Loss)* | $-5.50MM | $-6.38MM | $-1.85MM |
| Stockholders Equity | $-5.81MM | $-6.08MM | $-6.89MM |
| Inventory | $0.39MM | $0.19MM | $0.00MM |
| Assets | $2.82MM | $2.19MM | $1.52MM |
| Operating Cash Flow | $-1.20MM | $-0.21MM | $-0.16MM |
| Capital expenditure | $0.06MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.06MM | $0.00MM | $0.09MM |
| Financing Cash Flow | $0.97MM | $0.21MM | $0.06MM |
| Earnings Per Share** | $-0.01 | $-0.01 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.